- Home
- IMUX vs ACNT Comparison
IMUX vs ACNT Comparison
Compare IMUX & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- ACNT
- Stock Information
- Founded
- IMUX 2016
- ACNT 1945
- Country
- IMUX United States
- ACNT United States
- Employees
- IMUX N/A
- ACNT N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- ACNT Steel/Iron Ore
- Sector
- IMUX Health Care
- ACNT Industrials
- Exchange
- IMUX Nasdaq
- ACNT Nasdaq
- Market Cap
- IMUX 100.0M
- ACNT 109.8M
- IPO Year
- IMUX N/A
- ACNT N/A
- Fundamental
- Price
- IMUX $1.07
- ACNT $11.47
- Analyst Decision
- IMUX Strong Buy
- ACNT
- Analyst Count
- IMUX 6
- ACNT 0
- Target Price
- IMUX $12.67
- ACNT N/A
- AVG Volume (30 Days)
- IMUX 885.0K
- ACNT 36.0K
- Earning Date
- IMUX 02-20-2025
- ACNT 11-12-2024
- Dividend Yield
- IMUX N/A
- ACNT N/A
- EPS Growth
- IMUX N/A
- ACNT N/A
- EPS
- IMUX N/A
- ACNT N/A
- Revenue
- IMUX N/A
- ACNT $178,417,000.00
- Revenue This Year
- IMUX N/A
- ACNT $5.81
- Revenue Next Year
- IMUX N/A
- ACNT $6.79
- P/E Ratio
- IMUX N/A
- ACNT N/A
- Revenue Growth
- IMUX N/A
- ACNT 6.56
- 52 Week Low
- IMUX $0.97
- ACNT $8.16
- 52 Week High
- IMUX $2.11
- ACNT $12.38
- Technical
- Relative Strength Index (RSI)
- IMUX 45.08
- ACNT 57.56
- Support Level
- IMUX $0.99
- ACNT $11.07
- Resistance Level
- IMUX $1.09
- ACNT $11.49
- Average True Range (ATR)
- IMUX 0.06
- ACNT 0.28
- MACD
- IMUX -0.00
- ACNT -0.06
- Stochastic Oscillator
- IMUX 39.89
- ACNT 61.45
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About ACNT Ascent Industries Co.
Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Ascent Tubular Products and the Specialty Chemicals Segment. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive and commercial transportation, brewery, chemical, petrochemical and other industries. The Specialty Chemicals segment produces specialty products for the pulp and paper, coatings, adhesives, sealants and elastomers (CASE), textile, automotive, household and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.